198 related articles for article (PubMed ID: 37856423)
1. CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway.
Chen J; Xu Q; Liu D; Li X; Guo M; Chen X; Liao J; Lei R; Li W; Huang H; Saw PE; Song E; Yan X; Nie Y
Cancer Commun (Lond); 2023 Nov; 43(11):1244-1266. PubMed ID: 37856423
[TBL] [Abstract][Full Text] [Related]
2. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
[TBL] [Abstract][Full Text] [Related]
3. Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breast.
Li J; Ho WY; Tsang JYS; Ni YB; Chan SK; Tse GM
Histopathology; 2019 Mar; 74(4):567-577. PubMed ID: 30383904
[TBL] [Abstract][Full Text] [Related]
4. miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors.
Gong C; Nie Y; Qu S; Liao JY; Cui X; Yao H; Zeng Y; Su F; Song E; Liu Q
Cancer Res; 2014 Aug; 74(16):4341-52. PubMed ID: 24980553
[TBL] [Abstract][Full Text] [Related]
5. Genomic characteristics of two breast malignant phyllodes tumors during pregnancy and lactation identified through whole-exome sequencing.
Lei T; Shen M; Deng X; Shi Y; Peng Y; Wang H; Chen T
Orphanet J Rare Dis; 2022 Oct; 17(1):382. PubMed ID: 36271373
[TBL] [Abstract][Full Text] [Related]
6. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
[TBL] [Abstract][Full Text] [Related]
7. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
[TBL] [Abstract][Full Text] [Related]
8. High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor.
Lei T; Yin L; Zhang H; Wei B; Chen H; Pu T; Yang L; Ye F; Zhang Z; Bu H
Int J Clin Oncol; 2020 Dec; 25(12):2025-2034. PubMed ID: 32803488
[TBL] [Abstract][Full Text] [Related]
9. Expression of TWIST1, Snail, Slug, and NF-κB and methylation of the TWIST1 promoter in mammary phyllodes tumor.
Do SI; Kim JY; Kang SY; Lee JJ; Lee JE; Nam SJ; Cho EY
Tumour Biol; 2013 Feb; 34(1):445-53. PubMed ID: 23150175
[TBL] [Abstract][Full Text] [Related]
10. Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
Cha YJ; Koo JS
PLoS One; 2020; 15(8):e0238466. PubMed ID: 32857809
[TBL] [Abstract][Full Text] [Related]
11. CD34, CD117, and actin expression in phyllodes tumor of the breast.
Chen CM; Chen CJ; Chang CL; Shyu JS; Hsieh HF; Harn HJ
J Surg Res; 2000 Dec; 94(2):84-91. PubMed ID: 11104647
[TBL] [Abstract][Full Text] [Related]
12. In phyllodes tumors of the breast expression of SPARC (osteonectin/BM40) mRNA by in situ hybridization correlates with protein expression by immunohistochemistry and is associated with tumor progression.
Kim NI; Kim GE; Lee JS; Park MH
Virchows Arch; 2017 Jan; 470(1):91-98. PubMed ID: 27909812
[TBL] [Abstract][Full Text] [Related]
13. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
Tan PH
Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
[TBL] [Abstract][Full Text] [Related]
14. IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.
Bellezza G; Prosperi E; Del Sordo R; Colella R; Rulli A; Sidoni A
Int J Surg Pathol; 2016 Feb; 24(1):37-42. PubMed ID: 26353850
[TBL] [Abstract][Full Text] [Related]
15. mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours.
Jones AM; Mitter R; Poulsom R; Gillett C; Hanby AM; Tomlinson IP; Sawyer EJ;
J Pathol; 2008 Dec; 216(4):408-17. PubMed ID: 18937276
[TBL] [Abstract][Full Text] [Related]
16. Recent insights into the molecular pathogenesis of mammary phyllodes tumours.
Karim RZ; O'Toole SA; Scolyer RA; Cooper CL; Chan B; Selinger C; Yu B; Carmalt H; Mak C; Tse GM; Tan PH; Putti TC; Lee CS
J Clin Pathol; 2013 Jun; 66(6):496-505. PubMed ID: 23404800
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors.
Lien HC; Wang CC; Huang CS; Yang YW; Kuo WH; Yao YT
Virchows Arch; 2013 Feb; 462(2):155-61. PubMed ID: 23291960
[TBL] [Abstract][Full Text] [Related]
18. Gene Expression Profiling of Fibroepithelial Lesions of the Breast.
Li X; Vail E; Maluf H; Chaum M; Leong M; Lownik J; Che M; Giuliano A; Cao D; Dadmanesh F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240386
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
Liu SY; Joseph NM; Ravindranathan A; Stohr BA; Greenland NY; Vohra P; Hosfield E; Yeh I; Talevich E; Onodera C; Van Ziffle JA; Grenert JP; Bastian BC; Chen YY; Krings G
Mod Pathol; 2016 Sep; 29(9):1012-27. PubMed ID: 27255162
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours.
Karim RZ; Scolyer RA; Tse GM; Tan PH; Putti TC; Lee CS
Pathology; 2009 Feb; 41(2):105-17. PubMed ID: 19152185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
